CYP2C19 INFLUENCE ON ESCITALOPRAM EFFICACY AND TOLERABILITY IN YOUTH WITH ANXIETY AND DEPRESSION

被引：2
|
作者：
Ramsey, Laura B. [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2018年 / 57卷 / 10期
关键词：
D O I：
10.1016/j.jaac.2018.07.736
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
21.3
引用
收藏
页码：S301 / S301
页数：1
相关论文
共 50 条
  • [21] CYP2C19 METABOLIZER STATUS PREDICTS ESCITALOPRAM PHARMACOKINETICS IN CHILDREN AND ADOLESCENTS
    Vaughn, Sam
    Poweleit, Ethan
    Desta, Zeruesenay
    Strawn, Jeffrey
    Ramsey, Laura
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S215 - S215
  • [22] Escitalopram population pharmacokinetics and remedial strategies based on CYP2C19 phenotype
    Liu, Xin
    Ju, Gehang
    Huang, Xinyi
    Yang, Wenyu
    Chen, Lulu
    Li, Chao
    He, Qingfeng
    Xu, Nuo
    Zhu, Xiao
    Ouyang, Dongsheng
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 346 : 64 - 74
  • [23] CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP
    Huezo-Diaz, Patricia
    Perroud, Nader
    Spencer, Edgar P.
    Smith, Rebecca
    Sim, Sarah
    Virding, Susanne
    Uher, Rudolf
    Gunasinghe, Cerisse
    Gray, Jo
    Campbell, Desmond
    Hauser, Joanna
    Maier, Wolfgang
    Marusic, Andrej
    Rietschel, Marcella
    Perez, Jorge
    Giovannini, Caterina
    Mors, Ole
    Mendlewicz, Julien
    McGuffin, Peter
    Farmer, Anne E.
    Ingelman-Sundberg, Magnus
    Craig, Ian W.
    Aitchison, Katherine J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (03) : 398 - 407
  • [24] Rapid CYP2C19 Genotype Testing: Comparison between Spartan RX CYP2C19 and Verigene CYP2C19
    Zhou, Y.
    Armstead, A. R.
    Coshatt, G. M.
    Brott, B. C.
    Sankaranarayanan, A.
    Limdi, N. A.
    Harada, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 845 - 845
  • [25] CYP2C19*2 and CYP2C19*3 allelomorphism in Turkish population
    Dogan, Ali
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 239 : 12 - 12
  • [26] Impact of the cytochrome CYP2D6 and CYP2C19 phenotype on venlafaxine efficacy in major depression
    Taranu, A.
    Gressier, F.
    Colle, R.
    Becquemont, L.
    Corruble, E.
    Verstuyft, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 38 - 38
  • [27] Efficacy and tolerability of Escitalopram in patients with moderate to severe depression with or without comorbid anxiety
    Stamouli, S.
    Vidalis, A.
    Stathakis, I.
    Bastas, H.
    Koulis, S.
    EUROPEAN PSYCHIATRY, 2008, 23 : S207 - S207
  • [28] Impact of CYP2C19 and CYP2D6 Genotype on Escitalopram, Risperidone, and Aripiprazole Treatment
    Jukic, Marin
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 24 - 25
  • [29] Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population
    Hanioka, N.
    Tsuneto, Y.
    Saito, Y.
    Sumada, T.
    Maekawa, K.
    Saito, K.
    Sawada, J.
    Narimatsu, S.
    XENOBIOTICA, 2007, 37 (04) : 342 - 355
  • [30] CYP2C19, SLC6A4, AND HTR2A INFLUENCE RESPONSE TO ESCITALOPRAM IN A PROSPECTIVE TRIAL OF ADOLESCENTS WITH GENERALIZED ANXIETY DISORDER.
    Poweleit, E.
    Strawn, J.
    Mills, J.
    Schroeder, H.
    Mossman, S.
    Varney, S.
    Desta, Z.
    Bousman, C.
    Ramsey, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S24 - S24
12345